Habush Habush & Rottier S.C. ® > Blog > Rhinelander personal injury attorneys > Wisconsin to receive $4.27 million in Risperdal marketing settlement

Wisconsin to receive $4.27 million in Risperdal marketing settlement

Posted under Rhinelander personal injury attorneys

The manufacturer of Risperdal, an anti-psychotic drug, has settled a lawsuit that accused it of using sneaky and illegal marketing tactics.

Risperdal, made by Janssen Pharmaceuticals Inc., is approved by the Food and Drug Administration to treat schizophrenia and bipolar disorder. Pharmaceutical companies are only permitted to market their products as treatments for the conditions the for which they have FDA approval.

The lawsuit against Janssen, a subsidiary of Johnson & Johnson, alleged the company ghostwrote articles in various medical journals to push Risperdal as a viable treatment for dementia. The company denies any sort of guilt in the settlement, making claims that it wants to avoid a lengthy and costly legal battle.

Manufacturers of all products, not just pharmaceuticals, have an obligation to ensure their marketing strategies do not deceive consumers. If you have been hurt as a result of misleading marketing, you may be able to hold the product’s manufacturer accountable for your injuries. Contact the product liability attorneys of Habush Habush & Rottier S.C. ® at 1-800-242-2874 to learn more about how a personal injury lawyer can help you.